3 Reasons to Avoid Marijuana Stocks in 2019

Owing to bad publicity and stratospheric valuations, marijuana stocks like Tilray Inc (NASDAQ:TLRY) are bad short-term plays.

| More on:

2018 has been a rough year for stocks, and marijuana stocks have been among those hit the hardest. After an unprecedented rally in late summer, cannabis stocks have retreated to the point where many of them have erased their gains for the year. Now, it’s time for investors to decide whether they want to give this sector another go in 2019.

Right now, it’s looking like that’s probably not a good idea. Although upcoming quarterly reports could reveal earnings surprises that would send cannabis stocks higher, I’m not overly optimistic. Canopy Growth has already released an earnings report that included recreational cannabis “test shipments,” and the results weren’t great. In Q2, Canopy posted its slowest revenue growth to date, despite the end of that quarter being right before legalization. We’ll have to wait and see how three full months of legalization plays out, but for now, things aren’t pretty.

In my estimate, there are three main reasons why cannabis stocks are not to be touched in 2019 — unless, of course, there is some earnings surprise on the horizon. I’ll start with the most obvious.

They’re overvalued

Cannabis stocks are generally priced high relative to sales and book value. For an example, look no further than Tilray (NASDAQ:TLRY). At the time of this writing, the company trades at 217 times sales and 37 times book value. It’s normal for early-stage growth stocks to be a little expensive. And Tilray is indeed a fast-growing enterprise, with 85% year-over-year revenue growth. But this company’s extraordinarily high valuation is totally beyond what we see in other high-growth sectors, like tech.

Shopify, for example, trades at 18 times sales and 10 times book value. This is within the realm of sanity. But Tilray is over 10 times as expensive as Shopify in terms of price/sales, and its revenue growth isn’t even that much higher.

Equity is being diluted

Another issue with cannabis stocks is the fact that their equity is constantly being diluted to fund acquisitions. The best example here would be Aphria (TSX:APHA)(NYSE:APHA), which did at least three major acquisitions last year, issuing new shares every single time. If these acquisitions don’t pay off, then each Aphria share represents a smaller and smaller part of the pie. And many other cannabis companies are in the same boat.

They’re becoming victims of bad press

Last but not least, we have the simple fact that cannabis stocks are becoming the victims of bad press. Last week’s Aphria/Gabriel Grego fiasco wasn’t the only time this year that marijuana stocks came under fire by a well-known money manager. Earlier in the year, none other than Andrew Left came out swinging against Tilray, saying that it was more of a “stock operation” than a real company. Granted, publicity is a fickle thing, and media sentiment can change on a dime. But in the short term, it can influence investor sentiment, which, at this late moment in 2018, makes a strong case for not taking short-term positions in cannabis stocks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Investing

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Stock Market

CRA: Here’s the TFSA Contribution Limit for 2025

The TFSA is a tax-sheltered account that allows you to hold diversified asset classes at a low cost.

Read more »

Hourglass and stock price chart
Tech Stocks

1 Canadian Stock Ready to Surge Into 2025

There is a lot of uncertainty about the market in general as we move closer to the following year, but…

Read more »

think thought consider
Stock Market

Billionaires Are Selling Apple Stock and Picking up This TSX Stock Instead

Billionaires like Warren Buffett continue to trim stakes in Apple stock, with others picking up this long-term stock instead.

Read more »

ways to boost income
Dividend Stocks

1 Excellent TSX Dividend Stock, Down 25%, to Buy and Hold for the Long Term

Down 25% from all-time highs, Tourmaline Oil is a TSX dividend stock that offers you a tasty yield of 5%…

Read more »

canadian energy oil
Energy Stocks

Is Baytex Energy Stock a Good Buy?

Baytex just hit a 12-month low. Is the stock now oversold?

Read more »

Start line on the highway
Dividend Stocks

1 Incredibly Cheap Canadian Dividend-Growth Stock to Buy Now and Hold for Decades

CN Rail (TSX:CNR) stock is incredibly cheap, but should investors join insiders by buying the dip?

Read more »

bulb idea thinking
Dividend Stocks

Down 13%, This Magnificent Dividend Stock Is a Screaming Buy

Sometimes, a moderately discounted, safe dividend stock is better than heavily discounted stock, offering an unsustainably high yield.

Read more »

a man relaxes with his feet on a pile of books
Investing

Outlook for Sun Life Financial Stock in 2025

Sun Life is up 25% this year. Are more gains on the way?

Read more »